EXECUTIVE TEAM

Dr. Peter Skarsgard, MD

PRESIDENT, CO-FOUNDER

Dr. Skarsgard is a Cardiovascular Surgeon and Clinical Associate Professor of Surgery at the University of British Columbia, and Head of the Division of Cardiovascular Surgery at Vancouver General Hospital. His area of expertise is mitral valve repair and complex valvular surgery. Based upon a simple clinical observation, Dr. Skarsgard developed and patented concepts for devices aimed toward percutaneous treatment of mitral regurgitation, utilizing proven surgical principles. These ideas form the basis for Calla and Orion.

Vincent Ledoux, MSc

CHIEF OPERATING OFFICER, CO-FOUNDER

Mr. Ledoux is a Business and Strategy Specialist with a background in Corporations and Investment Banking worldwide. Since 2009, he has been deeply involved in startups - launching, advising and mentoring engineering and technology ventures. Vincent holds a Bachelor of Science in Economics and a Master of Science in Business Management from EMLyon Business School in France. While bringing valuable corporate and business inputs, Vincent will manage the day-to-day activities and coordinate the R&D.  

Dr. Jacqueline Saw, MD

CHIEF MEDICAL OFFICER

Dr. Saw is a Clinical Professor of Medicine at the University of British Columbia, and a Structural Interventional Cardiologist at the Vancouver General Hospital. She is a recognized expert and key opinion leader in percutaneous device delivery, left atrial appendage occlusion, and spontaneous coronary artery dissection. She has considerable clinical trial experience, and has been a driving force for understanding women's health in cardiovascular disease. Dr. Saw will lead the pre-procedure planning and device delivery effort, and bring important clinical trial design input to Vesalius Cardiovascular.

ADVISORY TEAM

Dr. Donald Ricci, MD

CLINICAL AND STRATEGIC ADVISORY

Dr. Ricci is the CEO and co-founder of Evasc. Don trained in cardiology at Stanford University and the University of California, San Diego, and has a 35-year history of experience in coronary intervention and structural heart disease. He was director of the Cardiovascular Medicine program at Vancouver Hospital and is a Clinical Professor of Medicine at the University of British Columbia. He is a co-inventor of a number of medical devices, is named inventor on numerous device patents, and has broad experience in licensing technology to major strategic partners in the vascular field. Don brings important clinical and strategic inputs to Vesalius. 

Dr. Christopher Durkin, MD

ECHOCARDIOGRAPHY ADVISORY

Dr. Durkin is a Clinical Assistant Professor of Anaesthesiology at the University of British Columbia, and a member of the Section of Cardiovascular Anaesthesiology at Vancouver General Hospital.  In addition to expertise in cardiovascular physiology and pharmacology, he holds National Board of Echocardiography Certification in Advanced Perioperative Transesophageal Echocardiography, and is an expert in 3D echo for intracardiac structural disease and procedures. Dr. Durkin brings critical inputs in 3D echo imaging, both procedurally and in planning, to Vesalius Cardiovascular.

Vesalius Cardiovascular Inc., 2016